A label can end a debate before the evidence is heard. From Nazi propaganda to "quack" science, see how labels are weaponized ...

Financials for First Quarter of Fiscal Year 2027 Ended June 30, 2026 will be released on Thursday, August 13, 2026Northvale, New Jersey--(Newsfile Corp. -) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ...

Recursion Pharmaceuticals, Inc. stock is a Hold: slow revenue, competition, cash burn & dilution risk despite Roche/Sanofi ...

NEWARK, Del., July 13, 2026 /PRNewswire/ -- The global time temperature indicator labels market is witnessing steady growth as pharmaceutical manufacturers, cold-chain logistics providers, and food ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Discusses FDA First Cycle Review Conference Call. [Operator Instructions] I would now like to turn the conference call over ...

Vertex Pharmaceuticals recently reported second-quarter 2026 results, with revenue rising to US$3,333.9 million and net income reaching US$1,099.8 million, and raised its full-year 2026 revenue ...

(OTC: NDTP), through its wholly owned subsidiary Good Salt Life, Inc., today announced a major expansion of the EPA-approved label for its flagship product, (EPA Reg. No. 96503-1-103745). The same ...

Tonix Pharmaceuticals (NASDAQ:TNXP) reports today. Explore the key operating questions around commercial preparation and pipeline execution, business execution, demand quality, and financial ...

RM-718 is an investigational, weekly-injectable, MC4R-specific agonist that has demonstrated the potential to reduce body weight and hunger in preclinical studies. RM-718 is designed to be highly ...

Pfizer’s Litfulo is already approved in alopecia areata; however, the success of the TRANQUILLO programme sets it up for ...

Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline CST with statistical significance at 6 months The most common adverse events ...

August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has ...